Quest PharmaTech Inc (QPT) — Cash Flow-to-Debt Ratio
Quest PharmaTech Inc (QPT) has a Cash Flow-to-Debt Ratio of -0.03x as of October 2025, meaning its operating cash flow of CA$-35.00K could theoretically repay 0% of its total liabilities (CA$1.25 Million) in one year. See Quest PharmaTech Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Quest PharmaTech Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Quest PharmaTech Inc across 13 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Quest PharmaTech Inc.
Annual Cash Flow-to-Debt Ratio for Quest PharmaTech Inc (1998–2025)
Year-by-year debt coverage analysis for Quest PharmaTech Inc. Check Quest PharmaTech Inc (QPT) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.44x | CA$-511.88K | CA$1.17 Million | ▼ -69.2% |
| 2024 | -0.26x | CA$-342.42K | CA$1.32 Million | ▲ +48.4% |
| 2023 | -0.50x | CA$-554.68K | CA$1.11 Million | ▼ -82.8% |
| 2022 | -0.27x | CA$-170.78K | CA$622.60K | ▲ +95.8% |
| 2021 | -6.46x | CA$-2.52 Million | CA$389.44K | ▼ -2021.7% |
| 2020 | -0.30x | CA$-6.38 Million | CA$20.95 Million | ▲ +55.3% |
| 2019 | -0.68x | CA$-6.91 Million | CA$10.14 Million | ▲ +7.5% |
| 2018 | -0.74x | CA$-7.33 Million | CA$9.95 Million | ▲ +88.3% |
| 2017 | -6.28x | CA$-4.61 Million | CA$733.49K | ▼ -3169.4% |
| 2016 | -0.19x | CA$-2.56 Million | CA$13.30 Million | ▲ +59.8% |
| 2015 | -0.48x | CA$-1.94 Million | CA$4.07 Million | ▲ +19.2% |
| 2014 | -0.59x | CA$-1.96 Million | CA$3.31 Million | ▲ +97.5% |
| 1998 | -23.57x | CA$-81.77K | CA$3.47K | — |